Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer
Open Access
- 25 June 2009
- journal article
- research article
- Published by Taylor & Francis Ltd in Nutrition and Cancer
- Vol. 61 (4), 544-553
- https://doi.org/10.1080/01635580902752262
Abstract
Development and progression of many malignancies, including colorectal cancer, are associated with activation of multiple signaling pathways. Therefore, inhibition of these signaling pathways with noncytotoxic natural products represents a logical preventive and/or therapeutic approach for colon cancer. Curcumin and resveratrol, both of which inhibit the growth of transformed cells and colon carcinogenesis, were selected to examine whether combining them would be an effective preventive and/or therapeutic strategy for colon cancer. Indeed, the combination of curcumin and resveratrol was found to be more effective in inhibiting growth of p53-positive (wt) and p53-negative colon cancer HCT-116 cells in vitro and in vivo in SCID xenografts of colon cancer HCT-116 (wt) cells than either agent alone. Analysis by Calcusyn software showed synergism between curcumin and resveratrol. The inhibition of tumors in response to curcumin and/or resveratrol was associated with the reduction in proliferation and stimulation of apoptosis accompanied by attenuation of NF-κB activity. In vitro studies have further demonstrated that the combinatorial treatment caused a greater inhibition of constitutive activation of EGFR and its family members as well as IGF-1R. Our current data suggest that the combination of curcumin and resveratrol could be an effective preventive/therapeutic strategy for colon cancer.Keywords
This publication has 32 references indexed in Scilit:
- Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivoCancer Research, 2008
- Curcumin enhances the effects of 5‐fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF‐1RInternational Journal of Cancer, 2007
- Resveratrol: A review of preclinical studies for human cancer preventionToxicology and Applied Pharmacology, 2007
- Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB PathwayClinical Cancer Research, 2007
- From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancerEmerging Therapeutic Targets, 2006
- RIα influences cellular proliferation in cancer cells by transporting RFC40 into the nucleusCancer Biology & Therapy, 2005
- Activation of PPARγ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFRAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer CellsOnline Journal of Public Health Informatics, 2003
- Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and FunctionsEndocrine Reviews, 1997
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997